Larazotide acetate 250 mcg, 60 caps
£65.00
Larazotide Acetate (AT-1001) is a synthetic octapeptide in oral capsule form, studied as a tight junction regulator and zonulin pathway antagonist. One of the few peptides with research focus specifically on intestinal epithelial permeability. Available to buy in the UK from BioLab Peptides: 250 mcg per capsule, 60 capsules per bottle, 99%+ purity.
- Purity: ≥99%
- Dose: 250 mcg per capsule
- Count: 60 capsules per bottle
- Also known as: AT-1001, Larazotide
- Mechanism: Zonulin antagonist, tight junction regulator
- Form: Oral capsules (not injection)
Buy Larazotide Acetate Capsules UK (250mcg x 60)
Larazotide Acetate is supplied as oral capsules containing 250 micrograms of peptide per capsule, 60 capsules per bottle. This is the acetate salt form of Larazotide (also designated AT-1001), a synthetic octapeptide derived from Vibrio cholerae zonula occludens toxin (ZOT). Unlike most research peptides that are administered by injection, Larazotide is designed for oral delivery because it acts locally in the intestinal lumen rather than systemically.
Why capsules and not injection?
Larazotide acts at the apical surface of intestinal epithelial cells in the small intestine. It is designed to remain in the gut lumen and is minimally absorbed into systemic circulation. Injection would not deliver it to its site of activity. Oral capsule administration is the appropriate research format.
Product Specifications
| Product Name | Larazotide Acetate Capsules |
| Research code | AT-1001 |
| Dose per capsule | 250 mcg (0.25 mg) |
| Capsules per bottle | 60 |
| Total peptide | 15 mg (60 x 250 mcg) |
| Amino acids | 8 (octapeptide) |
| Purity | ≥99% |
| Storage | Room temperature, away from moisture |
Research Background
Zonulin pathway antagonism. Zonulin is the only known physiological modulator of intercellular tight junctions in the small intestine. Larazotide was specifically designed to antagonise zonulin-mediated tight junction disassembly, preserving barrier function in the epithelial monolayer.
Intestinal permeability research. Larazotide has been studied most extensively in research models of increased intestinal permeability, including gluten-associated models, autoimmune gastrointestinal conditions, and leaky gut hypothesis investigation.
Oral bioavailability design. Most peptides are rapidly degraded in the GI tract, making oral administration ineffective. Larazotide was specifically designed to function locally in the intestinal lumen, with minimal systemic absorption required. This is why it has reached more advanced research stages than most peptides of similar size.
Related Products
For complementary gut and immune research, see BPC-157 (GI cytoprotection), KPV capsules (anti-inflammatory, also oral), and LL-37 (antimicrobial). Browse Immune Support and Recovery & Repair.
Frequently Asked Questions
Where can I buy Larazotide acetate in the UK?
Larazotide Acetate capsules are available to buy in the UK from BioLab Peptides. We ship same-day on orders before 2 PM with full Certificate of Analysis.
Is Larazotide a peptide or a drug?
Larazotide is a synthetic octapeptide (research chemical). It is not a licensed medicine in the UK. It is sold strictly for laboratory research use.
What is the difference between Larazotide and Larazotide acetate?
Larazotide acetate is the acetate salt form of the peptide, which is the standard laboratory-grade form. The peptide sequence is identical; the acetate is simply the counterion used in manufacturing.
For research and laboratory use only. Not for human or veterinary consumption.
Be the first to review “Larazotide acetate 250 mcg, 60 caps”
Related products
Reviews
There are no reviews yet.